| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 3 | — | — | 6 | 1 | 1 | 2 | — | 2 | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | ‡‡‡‡‡ |
|
| 2025 | ‡‡‡‡‡ |
|
| 2024 | ‡‡‡‡ |
|
| 2023 | ‡‡‡‡ |
|
| 2022 | ‡‡‡‡ |
|
| 2021 | ‡‡‡‡ |
|
| 2020 | ‡‡‡‡ |
|
| 2019 | ‡‡‡‡ |
|
| 2018 | ‡‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 285.01 | 447.96 | 1,168.08 | 1,460.73 |
| Receivables | 325.68 | 429.93 | 555.41 | 605.37 |
| Inventory | 545.40 | 597.98 | 702.63 | 783.12 |
| Other | — | — | — | — |
| 1,176.11 | 1,483.38 | 2,436.68 | 2,874.78 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 153.22 | 155.43 | 247.50 | 250.40 |
| ST’ Debt | 38.12 | 77.29 | 109.12 | 148.01 |
| Other | — | — | — | — |
| 500.66 | 641.23 | 745.71 | 786.26 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 231.26 | 292.92 | — | — |
—
|
| ’25 | 172.35 | 215.37 | 269.16 | 244.43 |
901.31
|
| ’24 | 152.19 | 202.48 | 203.98 | 223.47 |
782.12
|
| ’23 | 74.26 | 144.58 | 168.57 | 170.32 |
557.72
|
| ’22 | 42.19 | 104.40 | 133.71 | 108.54 |
388.83
|
| ’21 | 43.73 | 53.86 | 67.01 | 95.14 |
259.75
|
| ’20 | 24.35 | 39.05 | 47.67 | 45.56 |
156.62
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (29.54) | (6.36) | — | — |
—
|
| ’25 | 5.28 | (44.90) | (4.62) | 33.92 |
(10.32)
|
| ’24 | (9.65) | 61.59 | 11.91 | 88.60 |
152.45
|
| ’23 | (30.49) | 11.35 | (17.82) | (38.35) |
(75.32)
|
| ’22 | (27.73) | (33.57) | (0.10) | (0.80) |
(62.19)
|
| ’21 | 10.74 | (10.50) | (4.06) | (36.27) |
(40.09)
|
| ’20 | 3.83 | (14.48) | 2.62 | (5.51) |
(13.55)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (51.97) | (71.71) | — | — |
—
|
| ’25 | (11.82) | (60.04) | (14.95) | 19.52 |
(67.29)
|
| ’24 | (35.74) | 48.01 | (21.45) | 75.68 |
66.50
|
| ’23 | (45.54) | 3.48 | (46.05) | (51.54) |
(139.66)
|
| ’22 | (31.31) | (35.69) | (16.02) | (71.69) |
(154.71)
|
| ’21 | 9.16 | (11.71) | (6.76) | (40.51) |
(49.80)
|
| ’20 | 3.71 | (31.38) | (0.34) | (41.02) |
(69.03)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.24 | 1.23 | — | — |
—
|
| ’25 | 0.30 | 0.44 | 0.52 | 0.11 |
1.37
|
| ’24 | 0.26 | 0.35 | 0.45 | 0.46 |
1.53
|
| ’23 | 0.11 | 0.41 | 0.39 | 0.26 |
1.16
|
| ’22 | (0.09) | 0.18 | 0.32 | 0.18 |
0.59
|
| ’21 | 0.08 | 0.10 | 0.15 | 0.23 |
0.58
|
| ’20 | 0.03 | 0.00 | 0.13 | 0.13 |
0.30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 5.46 | 8.75 | 13.87 | 14.97 | — | — | — |
Low Price
|
| — | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.53 | 21.07 | 34.40 | 45.12 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,209 | 1,590 | 2,023 | 2,513 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.32 | 0.35 | 0.39 | 0.36 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 388.83 | 557.72 | 782.12 | 901.31 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.22% | 49.53% | 50.06% | 44.39% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67.36 | 116.22 | 166.30 | 135.19 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.32% | 20.84% | 21.26% | 15.00% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 50.56 | 96.85 | 131.27 | 121.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.37 | 8.09 | 9.97 | 16.33 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.56 | 9.27 | 12.57 | 14.04 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.66 | 1.29 | 1.67 | 1.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.05) | (1.25) | 2.45 | (0.16) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.56) | (1.07) | (1.38) | (0.89) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.61) | (2.32) | 1.07 | (1.05) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.71 | 15.39 | 17.62 | 30.08 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.24 | 60.17 | 62.21 | 64.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.55 | 14.47 | 9.15 | 26.84 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.46 | 2.01 | 1.20 | 2.81 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.70 | 1.21 | 0.86 | 1.31 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.79 | 1.67 | 0.86 | 1.83 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.98) | (6.66) | 10.14 | (24.55) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (62.19) | (75.32) | 152.45 | (10.32) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (92.52) | (64.34) | (85.95) | (56.97) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (154.71) | (139.66) | 66.50 | (67.29) | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 567.59 | 675.45 | 842.15 | 1,690.97 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 77.01 | 92.07 | 182.81 | 288.05 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (262.14) | (192.94) | (265.15) | (880.02) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 812.17 | 926.16 | 1,095.91 | 1,930.51 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.43% | 5.67% | 6.19% | 3.98% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.71% | 8.17% | 11.36% | 6.51% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.84% | 8.90% | 10.25% | 6.22% | ‡‡‡‡ | — | — |
ROE
|
ACMR Research has delivered explosive growth over the past decade, transforming from a niche semiconductor cleaning equipment provider into a hypergrowth powerhouse, with revenue surging from $27 million in 2016 to $782 million in 2024—a staggering 55% CAGR fueled by AI, EVs, and 5G demand. Despite early US-China trade tensions that once threatened its 90%+ China revenue reliance, the company rebounded sharply, tripling sales post-2018 and capitalizing on chip shortages and advanced packaging needs for tools like Tahoe and Ultrafab. Operational leverage shines through, with revenue per employee doubling to $387,000 and EPS rocketing 2,286% to $1.67, while gross margins edged up to 50% amid R&D investments.
Profitability has matured impressively, flipping EBT to $166 million (21% margins) and generating positive FCF of $1.07 per share in 2024 after capex-fueled expansions, backed by a fortress balance sheet featuring $1.1 billion equity and net cash. Valuations scream bargain—trailing P/E at 9x, P/S at 1.2x, and EV/Sales at 0.86x versus sector multiples—positioning ACMR as undervalued growth amid peers like Lam Research. Analysts forecast 19% revenue CAGR to $1.3 billion by 2027, with EPS hitting $2.62.
Yet caution flags abound: heavy insider selling ($32 million proceeds, no buys), stock trading 89% above 2024 highs and well over analyst targets (mean 31% downside), plus cyclical risks and geopolitical tensions from China exposure. Echoing past semi booms and busts, this high-conviction hold for macro bulls demands vigilant monitoring of tariffs, AI capex cycles, and inventory gluts—potentially rewarding patient investors with re-rating upside or volatility traps.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.